Falls have become the leading cause of injury-related deaths for senior citizens. People are living longer than ever, and that means there are a lot more older and more frail adults in the world noW, according to researchers from the CDC. Their new report finds that in 2003, more than thirteen-thousand people over age sixty died after falling. The report also shows men are more likely to die from falling than women. Researchers say there are ways to reduce the risk of falls, such as exercising regularly, having your eyes checked, improving the lighting around your home, and seniors should always ask a doctor to review all the medications their taking to check for potential side effects.
Broken bones and injured ligaments could take a longer time to heal in people who smoke compared with non-smokers. Two new studies from the Washington University School of Medicine in Missouri used mice to examine the effects of smoking on fractures and ligament injuries. The healing process in mice exposed to cigarette smoke did take longer, and researchers were actually able to see the delays on a cellular level. Previous studies show smokers have higher rates of hip fractures, and that smoking impairs soft tissue wound healing. Study led by researchers at the Washington University School of Medicine in St. Louis, MO and published in the Journal of Orthopaedic Research.
There's new evidence that the pain reliever, Naproxen, could be associated with heart problems. Researchers had been reviewing comparison data on the safety of Celebrex versus Naproxen for patients at high risk for Alzheimer's disease. More than eight-percent of study participants on Naproxen had a stroke, heart attack, or congestive heart failure during the three-year study. Only about five and a half percent of patients on either Celebrex or a Placebo had such heart problems. Researchers admit additional and larger studies on Naproxen need to be done before drawing any final conclusions on its potential risks. Naproxen is sold under the brand name, Aleve. The study led by researchers at Johns Hopkins University school of public health and published in PLoS Clinical Trials and is available at www.plosclinicaltrials.org.